Exact Sciences Corporation

EXAS Healthcare
$101.74 +$0.24 (0.24%)
Market Cap: $19.31 B
Gurus Holding
8
Popularity Rank
#670
% of Shares Held
2.62%
Net Activity (Q3 2025)
+$120.15 M

Guru Ownership Over Time

Guru Analysis for Exact Sciences Corporation (EXAS)

Exact Sciences Corporation (EXAS), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2025, a total of 8 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $505.33 M.

Top institutional holders include Catherine Wood and Cliff Asness.

Institutional sentiment is currently Strongly Bullish. This is evidenced by a $120.15 M net inflow during the quarter.

Recent activity highlights Catherine Wood who dramatically increased their stake. Conversely, Joel Greenblatt reduced exposure by 89.5%.

Portfolio Manager % of portfolio Activity Shares Value Peroid
0.71% Add 6072589.0% 2,186,168 $119.61 M Q3 2025
0.06% Add 3.6% 1,817,177 $97.49 M Q3 2025
0.04% Add 13.7% 601,376 $32.9 M Q3 2025
0.00% Add 25.5% 198,287 $10.85 M Q3 2025
0.05% Add 25.2% 93,237 $5.1 M Q3 2025
0.01% Reduce -5.7% 44,316 $2.42 M Q3 2025
0.00% Reduce -68.9% 14,928 $816,711 Q3 2025
0.00% Reduce -89.5% 11,430 $625,335 Q3 2025

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown(Q3 2025)

+$130.23 M
Total Buy Value
New Buys: 0
Additions: 5
-$10.08 M
Total Sell Value
Reductions: 3
Sold Out: 1

Guru Consensus (Q3 2025)

Based on recent guru activity
Net Sellers
4
Net Buyers
5

FAQs for Exact Sciences Corporation (EXAS)

Top Guru holders include Catherine Wood ($119.61 M), Cliff Asness ($97.49 M), Renaissance Technologies ($32.9 M). Collectively, tracked Gurus hold 4.97 M shares.

Based on recent 13F filings, the sentiment is **Positive (Net Buy)**. There was a net inflow of $120.15 M, with 5 Gurus buying and 4 Gurus selling.

In the recent quarter, 3 Gurus reduced their positions, and 1 Gurus sold out of EXAS completely. Total sell value was $10.08 M.

Yes, 0 Gurus opened new positions in EXAS, and 5 added to their existing holdings. Total buy value was $130.23 M.